Evidence that Extreme Dilutions of Paclitaxel and Docetaxel Alter Gene Expression of In Vitro Breast Cancer Cells

 

 Permissions and Reprints

Abstract

Background Gene expression analysis of cells treated with extreme dilutions or micro amounts of drugs has been used to provide useful suggestions about biological responses. However, most of the previous studies were performed on medicines being prepared from a variety of herbal and metal sources. This study investigated the effects of ultramolecular dilution of the taxane anti-cancer drugs, which are not commonly used in homeopathic medicines, on mRNA expression profiles of five key genes (p53, p21, COX-2, TUBB2A and TUBB3) in the breast cancer cell line MCF-7.

Method MCF-7 cells were exposed to paclitaxel (Taxol) or docetaxel (Taxotere) preparations (6X, 5C and 15C dilutions prepared from pharmacological concentration of 25 nmol/L) for 72 hours. The cell culture groups were evaluated with the trypan blue dye exclusion method for the proliferation/cytotoxicity rates, immuno-staining β-tubulin for microtubule organization, and reverse transcription polymerase chain reaction for gene expression levels.Fold-change in gene expression was determined by the ΔΔCt method.

Results The administration of diluted preparations had little or no cytotoxic effect on MCF-7 cells, but altered the expression of genes analyzed with a complex effect. According to the ΔΔCt method with a five-fold expression difference (p < 0.05) as a cut-off level, ultra-high dilutions of paclitaxel and docetaxel showed differential effects on the studied genes with a concentration-independent activity. Furthermore, the dilutions disrupted the microtubule structure of MCF-7 cells, suggesting that they retain their biological activity.

Conclusion Despite some limitations, our findings demonstrate that gene expression alterations also occur with ultra-high dilutions of taxane drugs.

• References

• 1 Ding LH, Shingyoji M, Chen F. , et al. Gene expression profiles of normal human fibroblasts after exposure to ionizing radiation: a comparative study of low and high doses. Radiat Res 2005; 164: 17-26
  CrossrefPubMedGoogle Scholar
• 2 Goodman R, Wei LX, Xu JC, Henderson A. Exposure of human cells to low-frequency electromagnetic fields results in quantitative changes in transcripts. Biochim Biophys Acta 1989; 1009: 216-220
  CrossrefPubMedGoogle Scholar
• 3 Sikdar S, Kumar Saha S, Rahman Khuda-Bukhsh A. Relative apoptosis-inducing potential of Homeopa-thic Condurango 6C and 30C in H460 lung cancer cells in vitro-Apoptosis-induction by homeopathic Condurango in H460 cells. J Pharmacopuncture 2014; 17: 59-69
  CrossrefPubMedGoogle Scholar
• 4 Sikdar S, Mukherjee A, Bishayee K. , et al. Post-cancer treatment with Condurango 30C shows amelioration of benzo[a]pyrene-induced lung cancer in rats through the molecular pathway of Caspase-3-mediated apoptosis induction: anti-lung cancer potential of Condurango 30C in rats. J Pharmacopuncture 2013; 16: 11-22
  PubMedGoogle Scholar
• 5 Olioso D, Marzotto M, Bonafini C, Brizzi M, Bellavite P. Arnica montana effects on gene expression in a human macrophage cell line. Evaluation by quantitative Real-Time PCR. Homeopathy 2016; 105: 131-147
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 Bigagli E, Luceri C, Dei A, Bernardini S, Dolara P. Effects of extreme dilutions of Apis mellifica preparations on gene expression profiles of human cells. Dose Response 2016; 14: 1559325815626685 . doi: 10.1177/1559325815626685
  CrossrefPubMedGoogle Scholar
• 7 Bigagli E, Luceri C, Bernardini S, Dei A, Filippini A, Dolara P. Exploring the effects of homeopathic Apis mellifica preparations on human gene expression profiles. Homeopathy 2014; 103: 127-132
  Article in Thieme ConnectPubMedGoogle Scholar
• 8 Marzotto M, Olioso D, Brizzi M, Tononi P, Cristofoletti M, Bellavite P. Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-low doses of Gelsemium sempervirens. BMC Complement Altern Med 2014; 14: 104
  CrossrefPubMedGoogle Scholar
• 9 Thangapazham RL, Gaddipati JP, Rajeshkumar NV. , et al. Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro. Integr Cancer Ther 2006; 5: 356-361
  PubMedGoogle Scholar
• 10 Thangapazham RL, Rajeshkumar NV, Sharma A. , et al. Effect of homeopathic treatment on gene expression in Copenhagen rat tumor tissues. Integr Cancer Ther 2006; 5: 350-355
  CrossrefPubMedGoogle Scholar
• 11 Merlin JL, Barberi-Heyob M, Bachmann N. In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines. Ann Oncol 2002; 13: 1743-1748
  CrossrefPubMedGoogle Scholar
• 12 Dai Y, Xie CH, Neis JP, Fan CY, Vural E, Spring PM. MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance. Head Neck 2011; 33: 786-791
  CrossrefPubMedGoogle Scholar
• 13 Ziaja-Sołtys M, Rzymowska J. The determination of changes in the expression of genes for selected specific transcriptional factors in in vitro ductal breast cancer cells under the influence of paclitaxel. Cell Mol Biol Lett 2011; 16: 610-624
  PubMedGoogle Scholar
• 14 Panno ML, Giordano F, Mastroianni F. , et al. Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells. FEBS Lett 2006; 580: 2371-2380
  CrossrefPubMedGoogle Scholar
• 15 Sharma M, Tuaine J, McLaren B. , et al. Chemotherapy agents alter plasma lipids in breast cancer patients and show differential effects on lipid metabolism genes in liver cells. PLoS One 2016; 11: e0148049 . doi: 10.1371/journal.pone.0148049
  CrossrefPubMedGoogle Scholar
• 16 Hernández-Vargas H, Rodríguez-Pinilla SM, Julián-Tendero M. , et al. Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat 2007; 102: 157-172
  CrossrefPubMedGoogle Scholar
• 17 Hernández-Vargas H, Palacios J, Moreno-Bueno G. Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis. Oncogene 2007; 26: 2902-2913
  CrossrefPubMedGoogle Scholar
• 18 Nallani SC, Goodwin B, Buckley AR, Buckley DJ, Desai PB. Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes. Cancer Chemother Pharmacol 2004; 54: 219-229
  PubMedGoogle Scholar
• 19 Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108
  CrossrefPubMedGoogle Scholar
• 20 Duarte ML, de Moraes E, Pontes E. , et al. Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell lines. Cancer Lett 2009; 279: 57-64
  CrossrefPubMedGoogle Scholar
• 21 Fauzee NJ. Taxanes: promising anti-cancer drugs. Asian Pac J Cancer Prev 2011; 12: 837-851
  PubMedGoogle Scholar
• 22 Howe LR. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res 2007; 9: 210
  CrossrefPubMedGoogle Scholar
• 23 Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer 2010; 10: 194-204
  CrossrefPubMedGoogle Scholar
• 24 Sprowl JA, Reed K, Armstrong SR. , et al. Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells. Breast Cancer Res 2012; 14: R2
  CrossrefPubMedGoogle Scholar
• 25 Dei A, Bernardini S. Hormetic effects of extremely diluted solutions on gene expression. Homeopathy 2015; 104: 116-122
  Article in Thieme ConnectPubMedGoogle Scholar
• 26 Bigagli E, Luceri C, Bernardini S, Dei A, Dolara P. Extremely low copper concentrations affect gene expression profiles of human prostate epithelial cell lines. Chem Biol Interact 2010; 188: 214-219
  CrossrefPubMedGoogle Scholar
• 27 Pusztai L. Markers predicting clinical benefit in breast cancer from microtubule-targeting agents. Ann Oncol 2007; 18 (Suppl. 12) xii15-xii20
  CrossrefPubMedGoogle Scholar
• 28 Gelmon K. The taxoids: paclitaxel and docetaxel. Lancet 1994; 344: 1267-1272
  CrossrefPubMedGoogle Scholar
• 29 Lobert S, Jefferson B, Morris K. Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells. Cytoskeleton (Hoboken) 2011; 68: 355-362
  CrossrefPubMedGoogle Scholar